Aberrant glycosylation of iga1 and anti-glycan antibodies in iga nephropathy: Role of mucosal immune system

Advances in Oto-Rhino-Laryngology

Volumn 72, Issue , 2011, Pages 60-63

  Novak, Jan ^a   Moldoveanu, Zina ^a   Julian, Bruce A ^a,b   Raska, Milan ^a,e   Wyatt, Robert J ^c   Suzuki, Yusuke ^f   Tomino, Yasuhiko ^f   Gharavi, Ali G ^d   Mestecky, Jiri ^a,b   Suzuki, Hitoshi ^a,f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^d Palacky University in Olomouc ^*  (United States)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; IMMUNOGLOBULIN A; POLYSACCHARIDE;

ANTIGEN ANTIBODY COMPLEX; CONFERENCE PAPER; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; MESANGIUM; MESANGIUM CELL; METABOLISM; MUCOSA; MUCOSAL IMMUNITY; PHYSIOLOGY;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN-ANTIBODY COMPLEX; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; MESANGIAL CELLS; MUCOUS MEMBRANE; POLYSACCHARIDES;

EID: 80052474168     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324607     Document Type: Conference Paper

References (10)

1. Julian BA, Novak J: IgA nephropathy: An update. Curr Opin Nephrol Hypertens 2004;13:171-179. (Pubitemid 38373139)
2. Suzuki H, Fun R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J: Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009;119:1668-1677.
3. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999;104:73-81. (Pubitemid 29534347)
4. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, Julian BA, Tomana M, Wyatt RJ, Edberg JE, Alarcón GS, Kimberly RP, Tomino Y, Mestecky J, Novak J: IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008;118:629-639. (Pubitemid 351206552)
5. Leung JCK, Poon PYK, Lai KN: Increased sialylation of polymeric immunoglobulin A1: Mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J Lab Clin Med 1999;133:152-160. (Pubitemid 29073239)
6. Moldoveanu Z, Wyatt RJ, Lee J, Tomana M, Julian BA, Mestecky J, Huang W-Q, Anreddy S, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J: Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 2007;71:1148-1154. (Pubitemid 46809135)
7. Monteiro RC, Halbwachs-Mecarelli L, Roque-Barreira MC, Noel LH, Berger J, Lesavre P: Charge and size of mesangial IgA in IgA nephropathy. Kidney Int 1985;28:666-671. (Pubitemid 16205803)
8. Smith AC, Molyneux K, Feehally J, Barratt J: O-Glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006;17:3520-3528. (Pubitemid 44865295)
9. Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y: Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 2008;19:2384-2395.
10. Bene MC, Faure GC: Mesangial IgA in IgA nephropathy arises from the mucosa. Am J Kidney Dis 1988;12: 406-409.